Search Results 331-340 of 17173 for GLP-1 therapy
Have previously had intolerance to GLP-1 agonist therapy resulting in treatment discontinuation. Was hospitalized (ie, > 24 hours) for any reason within 30 ...
The purpose of this study is to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive ...
They also research behavior therapy, treatment outcomes, causes of ... Your treatment begins with a one-on-one consultation at Mayo Clinic. Then ...
During the early phases (phases 1 and ... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long-term safety ...
This serious, rare heart condition present at birth needs surgery to correct. Know the symptoms and treatment ... Mayo Clinic has one ... Had to reduce blood ...
Learn about causes and treatment of this blood condition that mainly affects women and may cause blood clots and miscarriages.
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
If these don't help enough, you might get a prescription for medicines to reduce swelling and irritation, called inflammation, and relieve pain. One ...
The objectives of Aim 1 of this feasibility study are to develop a digitized myofunctional therapy protocol effective for OSA treatment Aim 2, to implement ...
... 1 receptor (IGF-1R) within the orbital microenvironment. While first-generation targeted therapies such as intravenous teprotumumab proved highly ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!